Thus, our overall findings point toward a role for DPP4 in identifying NAFLD and metabolic diseases in individuals with and without obesity and T2DM, instead of being associated with fat mass and body adiposity itself. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.